While PCa suspicion continues to be based on serum prostate-specific antigen (PSA) elevation or abnormal digital rectal examination (DRE), the detection of csPCa has improved since the introduction of multiparametric magnetic resonance imaging (mpMRI) and guided biopsies [6,7]. This evidence concerns the gene KLK3 and posterior cortical atrophy.